Journals

Explore novel research, stay current on clinical trials, and find answers to your clinical care questions in case reports.
JTO cover 1

Complimentary access to the JTO and a 25% discount on the publication fees for the newest open-access IASLC journal, JTO CRR. Both JTO and JTO CRR feature novel research about the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO is among the top 5% of all oncology journals and the leading journal that is entirely focused on thoracic oncology.

JTO-CRR_Hero-0820 - Cropped.jpg

JTO and JTO CRR feature novel research about the prevention, detection, diagnosis, and treatment of all thoracic malignancies. With an Impact Factor of 15.609, JTO is among the top 5% of all oncology journals and the leading journal that is entirely focused on thoracic oncology. It emphasizes a multidisciplinary approach and includes original research, reviews and opinion pieces. JTO CRR, IASLC’s open access companion title, publishes a range of manuscripts from subset analyses of published trials to high-quality case reports.

JTO by the Numbers

13
out of 242 in 2020 Oncology Journals
4
out of 64 in 2020 Respiratory Journals
15.609
Impact Factor (up from 13.357 in 2019)
1,704%
increase in 6 years full-text article downloads

Recent journal articles

Discover the JTO

JTO.org offers numerous ways to stay abreast of novel research and information vital to your daily oncology practice. Join the JTO reader community to:

JTO RSS Feed

JTO articles

Subscribe to receive alerts about new content from JTO 

Searches, Citations, or Collection

Searches, Citations or Collection

Subscribe to receive alerts about saved searches, citations, or collections

Monthly Quick Poll

Journals stock poll

Participate in the monthly Quick Poll

Journal of Thoracic Oncology Impact Factor Continues to Increase

JTO cover 1

The JTO, the official journal of the IASLC, now ranks 11th out of all 244 oncology journals and 3rd out of all 64 respiratory system journals.

More than 80 international experts compose the JTO Editorial Board, allowing for a quick turn-around time of 5.4 days to initial decision, and an average of 7 days for revisions, a fast track category, publish on acceptance (within 5 days), and promotion of select articles via social media and press releases.

JTO emphasizes a multidisciplinary approach and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces. Authors can take advantage of Elsevier's Researcher Academy, Navigate your research journey with Researcher Academy—free e-learning modules on navigating your career developed by global experts.

JTO reviewers are given the privilege of getting the first look at novel research, phase III data, and potentially practice-changing concepts. Email your CV to journals@iaslc.org

New JTO Collections

JTO

Statistics in Oncology Series

This collection of articles covers fundamental statistical principles and recommendations for best practice.

JTO

Lung Cancer Worldwide Editorials

These articles offer a synopsis of lung cancer epidemiology, screening, prevention, diagnosis and therapy in different countries all over the world.

Discover the JTO CRR

Providing a more clinical focus, the JTO CRR contains phase I thoracic oncology clinical trials and single-arm phase II trials, as well as case reports, subset analyses of a published trials, database analyses, retrospective trials, and large single-institution series.

JTO CRR RSS Feed